UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Shortened Courses of Antibiotics for Bacterial Infections: A Systematic Review of Randomized Controlled Trials

Pharmacotherapy, 2018-06, Vol.38 (6), p.674-687

2018

Volltextzugriff (PDF)

Vancomycin-resistant enterococcal bacteremia pharmacotherapy

The Annals of pharmacotherapy, 2015-01, Vol.49 (1), p.69-85

2015

Volltextzugriff (PDF)

Omadacycline: A Modernized Tetracycline

Clinical infectious diseases, 2019-08, Vol.69 (Supplement_1), p.S1-S5

Gallagher, Jason C

2019

Volltextzugriff (PDF)

Drug Fever

Pharmacotherapy, 2010-01, Vol.30 (1), p.57-69

2010

Volltextzugriff (PDF)

Allergic cross-sensitivity between penicillin, carbapenem, and monobactam antibiotics: what are the chances?

The Annals of pharmacotherapy, 2009-02, Vol.43 (2), p.304-315

2009

Volltextzugriff (PDF)

Taking on the Fundamental Questions in Infectious Diseases Two-at-a-Time

Clinical infectious diseases, 2023-05, Vol.76 (9), p.1613-1614

Gallagher, Jason C

2023

Volltextzugriff (PDF)

Lack of Benefit of Fluvoxamine for COVID-19

JAMA : the journal of the American Medical Association, 2023-01, Vol.329 (4), p.291

2023

Volltextzugriff (PDF)

Bacteria Keep Reminding Us: There Are No Silver Bullets

Clinical infectious diseases, 2020-12, Vol.71 (10), p.2717-2718

Gallagher, Jason C

2020

Volltextzugriff (PDF)

Beta-Lactam Hypersensitivity and Cross-Reactivity

Journal of pharmacy practice, 2014-12, Vol.27 (6), p.530-544

2014

Volltextzugriff (PDF)

Improving antibiotic utilization through an outpatient stewardship initiative

Antimicrobial stewardship & healthcare epidemiology : ASHE, 2023, Vol.3 (1), p.e120-e120, Article e120

2023

Volltextzugriff (PDF)

β-lactam/β-lactamase inhibitor combinations: from then to now

The Annals of pharmacotherapy, 2015-01, Vol.49 (1), p.86-98

2015

Volltextzugriff (PDF)

Eravacycline: The Tetracyclines Strike Back

The Annals of pharmacotherapy, 2019-11, Vol.53 (11), p.1124-1135

2019

Volltextzugriff (PDF)

Successful immunomodulators for the treatment of COVID-19 have opened the pathway for comparative trials

Clinical microbiology and infection, 2023-01, Vol.29 (1), p.7-9

2023

Volltextzugriff (PDF)

Appropriateness of prescribed oral antibiotic duration at the time of hospital discharge

Antimicrobial stewardship & healthcare epidemiology : ASHE, 2022, Vol.2 (1), p.e105-e105, Article e105

2022

Volltextzugriff (PDF)

Ertapenem-Containing Double-Carbapenem Therapy for Treatment of Infections Caused by Carbapenem-Resistant Klebsiella pneumoniae

Antimicrobial agents and chemotherapy, 2016-01, Vol.60 (1), p.669-673

2016

Volltextzugriff (PDF)

Outpatient Subcutaneous Antimicrobial Therapy (OSCAT) as a Measure to Improve the Quality and Efficiency of Healthcare Delivery for Patients With Serious Bacterial Infections

Frontiers in medicine, 2020-12, Vol.7, p.585658-585658

2020

Volltextzugriff (PDF)

Multicenter Study of Outcomes with Ceftazidime-Avibactam in Patients with Carbapenem-Resistant Enterobacteriaceae Infections

Antimicrobial agents and chemotherapy, 2017-07, Vol.61 (7)

2017

Volltextzugriff (PDF)

Clinical and economic benefits of fidaxomicin compared to vancomycin for Clostridium difficile infection

Antimicrobial agents and chemotherapy, 2015-11, Vol.59 (11), p.7007-7010

2015

Volltextzugriff (PDF)

Daptomycin therapy for osteomyelitis: a retrospective study

BMC infectious diseases, 2012-06, Vol.12 (1), p.133-133, Article 133

2012

Volltextzugriff (PDF)

Antibiotic Myths for the Infectious Diseases Clinician

Clinical infectious diseases, 2023-10, Vol.77 (8), p.1120-1125

2023

Volltextzugriff (PDF)

A Clinical Review and Critical Evaluation of Imipenem-Relebactam: Evidence to Date

Infection and drug resistance, 2020-01, Vol.13, p.4297-4308

2020

Volltextzugriff (PDF)

The Epidemiology, Evolution, and Treatment of KPC-Producing Organisms

Current infectious disease reports, 2018-06, Vol.20 (6), p.13-13, Article 13

2018

Volltextzugriff (PDF)

Lessons Learned from Coronavirus Disease 2019 (COVID-19) Therapies: Critical Perspectives From the Infectious Diseases Society of America (IDSA) COVID-19 Treatment Guideline Panel

Clinical infectious diseases, 2022-05, Vol.74 (9), p.1691-1695

2022

Volltextzugriff (PDF)

Clinical outcomes in patients infected with ertapenem-only-resistant Enterobacterales versus multi-carbapenem-resistant Enterobacterales

Journal of antimicrobial chemotherapy, 2024-08, Vol.79 (8), p.1929-1937

2024

Volltextzugriff (PDF)

Use of diagnostic and antimicrobial stewardship practices to improve Clostridioides difficile testing among SHEA Research Network hospitals

Infection control and hospital epidemiology, 2022-07, Vol.43 (7), p.930-934

2022

Volltextzugriff (PDF)

1 – 25 von 169

Suche als RSS-Feed

Aktive Filter

Nur zeigenMit Volltextzugriff

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(158)

Publikationsform

Sprache

Englisch
(169)
Japanisch
(18)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(123)
Life Sciences & Biomedicine
(112)
Humans
(87)
Infectious Diseases
(34)
Pharmacology & Pharmacy
(33)
Male
(30)
Female
(28)
Microbiology
(26)
Immunology
(21)
Anti-Bacterial Agents - Therapeutic Use
(19)
Adult
(18)
Biological And Medical Sciences
(16)
Middle Aged
(16)
Aged
(14)
Retrospective Studies
(14)
Animals
(13)
Medical Sciences
(13)
Risk Factors
(12)
Treatment Outcome
(11)
Prospective Studies
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Shortened Courses of Antibiotics for Bacterial Infections: A Systematic Review of Randomized Controlled Trials

Vancomycin-resistant enterococcal bacteremia pharmacotherapy

Omadacycline: A Modernized Tetracycline

Drug Fever

Allergic cross-sensitivity between penicillin, carbapenem, and monobactam antibiotics: what are the chances?

Taking on the Fundamental Questions in Infectious Diseases Two-at-a-Time

Lack of Benefit of Fluvoxamine for COVID-19

Bacteria Keep Reminding Us: There Are No Silver Bullets

Beta-Lactam Hypersensitivity and Cross-Reactivity

Improving antibiotic utilization through an outpatient stewardship initiative

β-lactam/β-lactamase inhibitor combinations: from then to now

Eravacycline: The Tetracyclines Strike Back

Successful immunomodulators for the treatment of COVID-19 have opened the pathway for comparative trials

Appropriateness of prescribed oral antibiotic duration at the time of hospital discharge

Ertapenem-Containing Double-Carbapenem Therapy for Treatment of Infections Caused by Carbapenem-Resistant Klebsiella pneumoniae

Outpatient Subcutaneous Antimicrobial Therapy (OSCAT) as a Measure to Improve the Quality and Efficiency of Healthcare Delivery for Patients With Serious Bacterial Infections

Multicenter Study of Outcomes with Ceftazidime-Avibactam in Patients with Carbapenem-Resistant Enterobacteriaceae Infections

Clinical and economic benefits of fidaxomicin compared to vancomycin for Clostridium difficile infection

Daptomycin therapy for osteomyelitis: a retrospective study

Antibiotic Myths for the Infectious Diseases Clinician

A Clinical Review and Critical Evaluation of Imipenem-Relebactam: Evidence to Date

The Epidemiology, Evolution, and Treatment of KPC-Producing Organisms

Lessons Learned from Coronavirus Disease 2019 (COVID-19) Therapies: Critical Perspectives From the Infectious Diseases Society of America (IDSA) COVID-19 Treatment Guideline Panel

Clinical outcomes in patients infected with ertapenem-only-resistant Enterobacterales versus multi-carbapenem-resistant Enterobacterales

Use of diagnostic and antimicrobial stewardship practices to improve Clostridioides difficile testing among SHEA Research Network hospitals

Aktive Filter

Suchergebnisse filtern